The Development of an In-vitro System to Identify Gynecologic Cancer Cells During Surgical Procedures

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02718209

Enrollment

Registered

2016-03-24

Start date

2016-04-30

Completion date

2018-04-30

Last updated

2016-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Malignancies

Brief summary

The purpose of this study is to examine the efficacy of mid-infrared spectroscopy together with Attenuated Total Reflection (ATR), for the detection of gynecological malignancies in real time during surgery.

Interventions

DEVICEMid-Infrared Spectroscopy with ATR

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Women with one or more tumors in reproductive system

Exclusion criteria

* Pregnant women * Unable to give consent

Design outcomes

Primary

Measure	Time frame	Description
Gynecological Malignancies Identified in Real Time	One hour	Results of Spectroscopy will be compared to frozen section/histopathology findings

Countries

Israel

Contacts

Primary ContactIlan Bruchim, MD

ilanb@hy.health.gov.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026